SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001267602-22-000017
Filing Date
2022-04-29
Accepted
2022-04-29 16:30:12
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A alim-20211231x10ka.htm   iXBRL 10-K/A 1316339
2 EX-31.3 alim-20211231xex31_3.htm EX-31.3 10512
3 EX-31.4 alim-20211231xex31_4.htm EX-31.4 9410
  Complete submission text file 0001267602-22-000017.txt   1609684

Data Files

Seq Description Document Type Size
4 EX-101.SCH alim-20211231.xsd EX-101.SCH 2164
5 EX-101.LAB alim-20211231_lab.xml EX-101.LAB 29923
6 EX-101.PRE alim-20211231_pre.xml EX-101.PRE 17828
8 EXTRACTED XBRL INSTANCE DOCUMENT alim-20211231x10ka_htm.xml XML 8079
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34703 | Film No.: 22876119
SIC: 2834 Pharmaceutical Preparations